Research of a new drug for fatty liver

| Fatty liver | News | Treatments

Research of a new drug for fatty liver

A promising new treatment for fatty liver disease has outperformed existing medications like Ozempic and Mounjaro in reducing liver fat, according to a recent study presented at a major liver disease conference.

| Hepatitis B | News | Treatments

Development of a new drug for the treatment of Hepatitis B virus

Hepalatide, used with pegylated interferon-alpha, shows promise for curing chronic hepatitis B by eliminating cccDNA from liver cells, according to early study results presented in a European liver congress.

| Fatty liver | News | Treatments

Efficacy of resmetirom in clinical practice and side effects

Resmetirom is the first approved drug for steatohepatitis, effective in reducing liver fat and fibrosis. Available in the U.S., it awaits approval in Europe due to high cost and limited access.

| Fatty liver | News | Treatments

Efimosfermin-alfa: New drug for fatty liver

Efimosfermin-alfa shows promise as a treatment for fatty liver disease, improving fibrosis and inflammation with monthly dosing, according to early clinical study results.

| Diseases | News | Treatments

Benefits of statins for liver diseases

A JAMA study shows that statins may benefit liver disease patients by lowering liver cancer risk, reducing complications, and improving fibrosis, especially with lipophilic and hydrophilic statins.

| Fatty liver | News

Relationship between fatty liver and kidney and gallbladder stones

Research indicates a potential relationship between fatty liver, kidney stones, and gallstones due to shared metabolic risk factors. More studies are required to validate these findings across different populations.

| Fatty liver | News | Treatments

Curcumin: food supplement for the treatment of fatty liver

Studies suggest that curcumin for fatty liver improves liver enzyme levels, reduces fibrosis, and has cardiovascular benefits. Although promising, more extensive trials are needed to validate its effectiveness as a long-term treatment option.

| News | Treatments

New treatment for primary biliary cholangitis

Primary biliary cholangitis is a rare liver disease causing bile duct damage. New therapies like seladelpar improve outcomes for treatment-resistant patients, offering better symptom management.

| Fatty liver | News | Treatments

Role of oral contraceptives in fatty liver

Oral contraceptives may be linked to fatty liver. Avoid alcohol, smoking, and sedentary lifestyles to reduce the risk.

| Hepatitis B | News | Treatments

Efficacy of a new treatment for hepatitis B

A new treatment for chronic hepatitis B using an antisense probe shows promising results, with 62% achieving theoretical cure and mild side effects.